HCV Screening, Management and Treatment Guidelines | March 13, 2024
Date of Presentation: March 13, 2024
Type: Past Presentation Training
Audience: Clinical
Program: Ending the Epidemics in Indian Country ECHO Program
Keywords: #hcv #hcv cure #hcv treatment #hep c #hepatitis
In this training, Dr. Paulina Deming, Dr. Karla Thornton, and Dr. Richard Manch discuss treatment and management of patients with hepatitis C in primary care, including medications, approaches to treatment, medication interactions, and treatment monitoring.
Recording:
Presented by:
Paulina Deming, PharmD, PhC | Karla Thornton, MD, MPH| Richard A. Manch, MD FAASLD, FACP, FACG
Paulina Deming, PharmD, PhC is an Associate Professor-Clinical Educator within the Pharmacy Practice and Administrative Sciences Department at the College of Pharmacy at the University of New Mexico Health Sciences Center (UNMHSC). Dr. Deming completed a general practice residency and infectious diseases pharmacotherapy residency at UNMHSC. Her interests are focused in hepatitis C virus (HCV) infections and clinical therapeutics. She is the assistant director for the Project ECHO (Extension for Community Healthcare Outcomes) HCV clinic and serves on Project ECHO’s expert faculty panel advising providers on HCV care in community, corrections, and within the Indian Health Services settings. Licensed as a pharmacist clinician, she sees patients through the UNMHSC’s HCV clinic and the Truman HCV-HIV coinfection clinic. In addition to teaching and clinical work, Dr. Deming has co-authored papers on the management of HCV infections as well as HCV treatment outcomes in real-world settings.
Karla Thornton, MD, MPH is a Professor in the Division of Infectious Diseases at the University of New Mexico School of Medicine in Albuquerque, New Mexico and currently serves as a Senior Associate Director of Project ECHO (Extension for Community Healthcare Outcomes). Her clinical expertise is in the treatment of viral hepatitis and she oversees all of the Viral Hepatitis Programs run out of the ECHO Institute including the Community, Corrections and Indian Country HCV TeleECHO programs. Through these programs, she trains primary care providers and their teams how to comprehensively care for patients with chronic HCV. In addition, she started the New Mexico Peer Education Project: Prisoner Health is Community Health in 2009, which trains New Mexico state prisoners to be peer educators and experts in HCV, other infectious diseases and addiction. She currently serves as the co-chair of the World Health Organization’s Guidelines Development Group for the treatment of persons with hepatitis C virus infection.
Richard A. Manch, MD, FAASLD, FACP, FACG is the Director of Hepatology with Arizona Liver Health and a Clinical Professor of Medicine at the University of Arizona.
Resources Provided:
- HCV & Project ECHO Overview (Presentation Slides)
- HCV Medications and Approach to Treatment (Presentation Slides)
- When to Refer Your HCV patient? (Presentation Slides)
Date added: February 15, 2024